| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 25.46B | 24.06B | 24.83B | 19.79B | 19.74B | 19.70B |
| Gross Profit | 4.49B | 4.23B | 4.20B | 3.49B | 3.63B | 3.96B |
| EBITDA | 2.14B | 1.78B | 1.72B | -189.00M | 1.14B | 1.42B |
| Net Income | 894.00M | 741.00M | 749.00M | -873.00M | 524.00M | 1.06B |
Balance Sheet | ||||||
| Total Assets | 34.44B | 35.83B | 34.05B | 30.29B | 27.62B | 27.67B |
| Cash, Cash Equivalents and Short-Term Investments | 5.71B | 6.19B | 2.92B | 3.90B | 3.33B | 4.42B |
| Total Debt | 7.73B | 6.76B | 7.97B | 6.24B | 3.52B | 3.27B |
| Total Liabilities | 15.64B | 14.80B | 15.31B | 12.95B | 10.27B | 10.78B |
| Stockholders Equity | 18.79B | 21.02B | 18.74B | 17.33B | 17.35B | 16.89B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.53B | -2.32B | -2.23B | -1.14B | 2.38B |
| Operating Cash Flow | 0.00 | 4.81B | 55.00M | -1.07B | -506.00M | 3.05B |
| Investing Cash Flow | 0.00 | -120.00M | -2.55B | -871.00M | -608.00M | -544.00M |
| Financing Cash Flow | 0.00 | -1.44B | 1.49B | 2.48B | 22.00M | -1.61B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥351.00B | 16.17 | 7.67% | 0.91% | 11.51% | 46.17% | |
74 Outperform | ¥100.84B | 18.23 | 7.00% | 3.02% | 8.49% | -0.33% | |
73 Outperform | ¥55.40B | 14.14 | ― | 2.54% | 3.47% | -12.26% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥22.55B | 29.60 | ― | 1.73% | -3.07% | -1.15% | |
62 Neutral | ¥35.29B | 28.29 | ― | 3.56% | -2.79% | -35.37% | |
52 Neutral | ¥93.64B | 29.26 | 5.02% | 3.23% | -21.03% | -91.77% |